share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4：持股變動聲明
SEC announcement ·  04/02 01:36
牛牛AI助理已提取核心訊息
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
輝瑞公司 [PFE] 的舉報人尚塔努·納拉延於2024年3月28日參與了一筆交易。公告中未披露交易的具體細節，例如行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。因此，行動後股票的總價值仍然未知。這些信息對於追蹤內幕活動作爲公司財務狀況和未來業績指標的投資者至關重要。
輝瑞公司 [PFE] 的舉報人尚塔努·納拉延於2024年3月28日參與了一筆交易。公告中未披露交易的具體細節，例如行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。因此，行動後股票的總價值仍然未知。這些信息對於追蹤內幕活動作爲公司財務狀況和未來業績指標的投資者至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。